Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema
Public ClinicalTrials.gov record NCT03728504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized double-blind/placebo study to evaluate the efficacy of ASN002 in subjects with severe chronic hand eczema.
Study identification
- NCT ID
- NCT03728504
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2019 (Actual)
- Primary completion
- Apr 29, 2020 (Actual)
- Completion
- Apr 29, 2020 (Actual)
- Last update posted
- May 9, 2023
2019 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 16
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Sweet Hope Research Specialty, Inc | Hialeah | Florida | 33016 | — |
| RM Medical Research, Inc. | Miami | Florida | 33174 | — |
| Advanced Clinical Research | Boise | Idaho | 83713 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46256 | — |
| Dermatology Specialists Research | Louisville | Kentucky | 40241 | — |
| DelRicht Research | New Orleans | Louisiana | 70115 | — |
| Maryland Laser Skin and Vein | Hunt Valley | Maryland | 21030 | — |
| BTC Network | Fort Gratiot | Michigan | 48059 | — |
| Minnesota Clinical Research Center | Fridley | Minnesota | 55432 | — |
| ActivMed Practices and Research, Inc. | Portsmouth | New Hampshire | 03801 | — |
| Dermatologists of Greater Colombus | Bexley | Ohio | 43209 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03728504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03728504 live on ClinicalTrials.gov.